DECODED, a podcast from Foundation Medicine

DECODED explores how Foundation Medicine's deep understanding of the genomic changes that contribute to cancer can direct patient-specific treatments. Through expert interviews, we get answers to questions about therapies that may transform patient care. Foundation Medicine offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. Foundation Medicine® and FoundationOne® are registered trademarks of Foundation Medicine, Inc.

Episodes

3. Using FoundationOne®Tracker to Bring Clarity to Treatment Response

April 23, 2024 • 10 mins

Today we are speaking with Dr. Jerry Mitchell, a medical oncologist and Director of Field Medical Oncology at Foundation Medicine. Before starting at Foundation Medicine, Dr. Mitchell spent 18 years providing direct patient care in a leading Midwest community practice. Although now at Foundation Medicine, he continues to practice medicine. He has both participated in clinical research and published in leading oncol...

Mark as Played

2. Genomic Testing to Identify Targetable Fusions

April 22, 2024 • 17 mins

Today we are speaking with Hanna Tukachinsky and Jessica Lee. Dr. Tukachinsky is a Senior Translational Scientist at Foundation Medicine who focuses on diagnostics and precision oncology. Ms. Lee is a Data Scientist at Foundation Medicine with expertise in genomic data and its clinical applications. They both are co-authors on a recently published paper titled Circulating Tumor DNA Enables Sensitive Detection of Ac...

Mark as Played

1. ctDNA Tumor Fraction Matters When Interpreting Liquid Biopsy Test Results

April 21, 2024 • 10 mins

Today we are talking with Dr. Lincoln Pasquina, Director of Clinical Development at Foundation Medicine. Dr. Pasquina leads a team that is on the cutting edge of the newest advances in comprehensive genomic profiling. These genomic tests help providers with therapy selection for their patients, expand the number of people who can enroll in trials, increase access to therapies for patients, and accelerate new drug d...

Mark as Played

Popular Podcasts

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.

The Nikki Glaser Podcast

Every week comedian and infamous roaster Nikki Glaser provides a fun, fast-paced, and brutally honest look into current pop-culture and her own personal life.

Stuff You Should Know

If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

Crime Junkie

If you can never get enough true crime... Congratulations, you’ve found your people.

Start Here

A straightforward look at the day's top news in 20 minutes. Powered by ABC News. Hosted by Brad Mielke.

Advertise With Us

DECODED, a podcast from Foundation Medicine

Episodes

.css-14f5ked{margin:0;word-break:break-word;display:-webkit-box;-webkit-box-orient:vertical;box-orient:vertical;-webkit-line-clamp:2;overflow:hidden;}3. Using FoundationOne®Tracker to Bring Clarity to Treatment Response

.css-r6mb8g{margin:0;word-break:break-word;display:-webkit-box;-webkit-box-orient:vertical;box-orient:vertical;-webkit-line-clamp:1;overflow:hidden;}2. Genomic Testing to Identify Targetable Fusions

1. ctDNA Tumor Fraction Matters When Interpreting Liquid Biopsy Test Results

Popular Podcasts

3. Using FoundationOne®Tracker to Bring Clarity to Treatment Response

2. Genomic Testing to Identify Targetable Fusions